| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate |
2002-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ddcf02611fe1e27038d541360ef7105 |
| publicationDate |
2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002177623-A1 |
| titleOfInvention |
Use of (Z) -2-cyano-3-hydroxy-but-2-enoic acid-(4' -trifluoromethylphenyl)-amide for treating multiple sclerosis |
| abstract |
The invention relates to the use of compound of Formula I in treating patients for the symptoms of multiple sclerosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013062442-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6967354-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110381942-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013062442-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012061062-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2471482-C1 |
| priorityDate |
2001-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |